WDAY Stock Analysis: Workday | NASDAQ
Software - Application | NASDAQ, USA | Market Cap: 47.749m USD | 12M Return: -16.7% | US98138H1014 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 427M
EPS Trend: 99.7%
Qual. Beats: 16
Rev. Trend: 99.8%
Qual. Beats: 4
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Workday, Inc. (NASDAQ: WDAY) is a U.S.-based provider of enterprise cloud applications, operating on a Software-as-a-Service (SaaS) subscription model. Its product suite covers financial management, human capital management, spend management, expense management, and planning, alongside industry-specific offerings such as supply chain and inventory tools for healthcare and student/faculty lifecycle solutions for education. The company is classified within the GICS Application Software sub-industry of the Information Technology sector.
Workday sells its solutions primarily through a direct sales organization and serves a broad range of end markets, including professional and business services, financial services, healthcare, manufacturing, media, education, government, technology, retail, and hospitality. The platform also includes Workday Extend, which allows customers and developers to build custom applications on the companys infrastructure. With a Large Cap market capitalization of approximately $45.7 billion USD and an October 2012 IPO date, Workday is a sizable publicly listed enterprise software vendor.
The company was originally incorporated in 2005 under the name North Tahoe Power Tools, Inc. and adopted the Workday name in July 2005. It is headquartered in Pleasanton, California, and serves customers in both the United States and international markets.
- Subscription revenue growth drives enterprise cloud market share gains
- AI product roadmap competition with SAP and Oracle intensifies
- Path to profitability remains central investor focus
| Net Income: 1.25b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA 4.62 > 1.0 |
| NWC/Revenue: -5.95% < 20% (prev 57.86%; Δ -63.81% < -1%) |
| CFO/TA 0.19 > 3% & CFO 3.08b > Net Income 1.25b |
| Net Debt (1.15b) to EBITDA (1.67b): 0.69 < 3 |
| Current Ratio: 0.91 > 1.5 & < 3 |
| Outstanding Shares: last quarter (250.2m) vs 12m ago -7.38% < -2% |
| Gross Margin: 75.80% > 18% (prev 75.58%; Δ 0.22% > 0.5%) |
| Asset Turnover: 60.07% > 50% (prev 49.88%; Δ 10.19% > 0%) |
| Interest Coverage Ratio: 11.74 > 6 (EBIT TTM 1.30b / Interest Expense TTM 111.0m) |
| A: -0.04 (Total Current Assets 5.97b - Total Current Liabilities 6.57b) / Total Assets 15.9b |
| B: 0.02 (Retained Earnings 342.0m / Total Assets 15.9b) |
| C: 0.08 (EBIT TTM 1.30b / Avg Total Assets 16.9b) |
| D: 0.69 (Book Value of Equity 6.46b / Total Liabilities 9.40b) |
| Altman-Z'' = 1.06 = BB |
| DSRI: 1.01 (Receivables 1.92b/1.67b, Revenue 10.2b/8.96b) |
| GMI: 1.00 (GM 75.58% / 75.80%) |
| AQI: 1.53 (AQ_t 0.51 / AQ_t-1 0.33) |
| SGI: 1.13 (Revenue 10.2b / 8.96b) |
| TATA: -0.12 (NI 1.25b - CFO 3.08b) / TA 15.9b) |
| Beneish M = -2.62 (Cap -4..+1) = A |
As of November 05, 2026, the stock is trading at USD 197.94 with a total of 2,474,293 shares traded. Over the past week, the price has changed by -3.66%, over one month by +4.75%, over three months by +19.93% and over the past year by -16.72%.
Current recommended Stop Loss: 182.20 (which is 8% or 2.2 ATR below the current price).
Workday has received a consensus analysts rating of 3.69. Therefore, it is recommended to hold WDAY.
- StrongBuy: 14
- Buy: 5
- Hold: 20
- Sell: 2
- StrongSell: 1
| Analysts Target Price | 209.3 | 5.7% |
P/E Trailing = 40.3523
P/E Forward = 14.9701
P/S = 4.7021
P/B = 7.38
P/EG = 0.5954
Revenue TTM = 10.2b USD
EBIT TTM = 1.30b USD
EBITDA TTM = 1.67b USD
Long Term Debt = 1.99b USD (from longTermDebt, last quarter)
Short Term Debt = 1.13b USD (from shortTermDebt, last quarter)
Debt = 4.55b USD (from shortLongTermDebtTotal, last quarter) + Leases 783.0m
Net Debt = 1.15b USD (calculated: Debt 4.55b - CCE 3.40b)
Enterprise Value = 48.9b USD (47.7b + Debt 4.55b - CCE 3.40b)
Interest Coverage Ratio = 11.74 (Ebit TTM 1.30b / Interest Expense TTM 111.0m)
EV/FCF = 17.19x (Enterprise Value 48.9b / FCF TTM 2.84b)
FCF Yield = 5.82% (FCF TTM 2.84b / Enterprise Value 48.9b)
FCF Margin = 28.00% (FCF TTM 2.84b / Revenue TTM 10.2b)
Net Margin = 12.32% (Net Income TTM 1.25b / Revenue TTM 10.2b)
Gross Margin = 75.80% ((Revenue TTM 10.2b - Cost of Revenue TTM 2.46b) / Revenue TTM)
Gross Margin QoQ = 75.41% (prev 76.24%)
Tobins Q-Ratio = 3.08 (Enterprise Value 48.9b / Total Assets 15.9b)
Interest Expense / Debt = 2.44% (Interest Expense 111.0m / Debt 4.55b)
Taxrate = 2.57% (33.0m / 1.28b)
NOPAT = 1.27b (EBIT 1.30b * (1 - 2.57%))
Current Ratio = 0.91 (Total Current Assets 5.97b / Total Current Liabilities 6.57b)
Debt / Equity = 0.71 (Debt 4.55b / totalStockholderEquity, last quarter 6.46b)
Debt / EBITDA = 0.69 (Net Debt 1.15b / EBITDA 1.67b)
Debt / FCF = 0.41 (Net Debt 1.15b / FCF TTM 2.84b)
Total Stockholder Equity = 7.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.40% (Net Income 1.25b / Total Assets 15.9b)
RoE = 16.78% (Net Income TTM 1.25b / Total Stockholder Equity 7.46b)
RoCE = 13.79% (EBIT 1.30b / Capital Employed (Equity 7.46b + L.T.Debt 1.99b))
RoIC = 12.82% (NOPAT 1.27b / Invested Capital 9.91b)
WACC = 6.62% (E(47.7b)/V(52.3b) * Re(7.03%) + D(4.55b)/V(52.3b) * Rd(2.44%) * (1-Tc(0.03)))
Discount Rate = 7.03% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -75.78 | Cagr: -3.37%
[DCF] Terminal Value 77.97% ; FCFF base≈2.66b ; Y1≈3.05b ; Y5≈4.49b
[DCF] Fair Price = 339.1 (EV 67.6b - Net Debt 1.15b = Equity 66.5b / Shares 196.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 99.66 | EPS CAGR: 25.59% | SUE: 4.0 | # QB: 16
Revenue Correlation: 99.82 | Revenue CAGR: 14.47% | SUE: 1.74 | # QB: 4
EPS current Quarter (2026-10-31): EPS=2.75 | Chg30d=+0.04% | Revisions=+40% | Analysts=36
EPS current Year (2027-01-31): EPS=11.09 | Chg30d=+0.10% | Revisions=+50% | GrowthEPS=+20.1% | GrowthRev=+11.7%
EPS next Year (2028-01-31): EPS=13.24 | Chg30d=+0.08% | Revisions=+88% | GrowthEPS=+19.4% | GrowthRev=+10.4%
[Analyst] Revisions Ratio: +89% (up=43, down=1)